# Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

> **NCT00553059** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 62 (actual)

## Conditions studied

- Chemotherapy-induced Nausea and Vomiting
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** dronabinol
- **DRUG:** palonosetron hydrochloride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00553059
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2020-10-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553059, "Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00553059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*